Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SGFEF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SGFEF and 80,000+ other tickers.
See exactly how SGFEF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SGFEF and 80,000+ other tickers.
Siegfried Holding AG is a global enterprise active in the life sciences industry. The company is dedicated to developing and manufacturing active pharmaceutical ingredients (APIs) and their intermediate compounds, as well as a diverse range of finished drug products. These include solid oral medications, sterile and aseptically filled injectable solutions, ophthalmic preparations, and inhalable treatments. It offers extensive contract development and manufacturing (CDMO) services, which span pharmaceutical and analytical development, process and analytical transfer, commercial-scale…
Siegfried Holding AG (SGFEF) Q2 2026 Earnings Call Transcript
NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry.
Siegfried Holding AG (SGFEF) Q4 2025 Earnings Call Transcript
Siegfried Holding AG (SGFEF) M&A Call Transcript
Jupiter Wellness (NASDAQ: JUPW - Get Free Report) and Siegfried (OTCMKTS:SGFEF - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Profitability This table compares Jupiter Wellness and Siegfried's net